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Background: Antineutrophil cytoplasmic antibody (ANCA)-associated crescentic glomerulonephritis (CGN) is a
major cause of rapidly progressive glomerulonephritis (RPGN). ANCA-associated CGN is generally classified into
pauci-immune RPGN, in which there are few or no immune complexes.
Case Presentation: A 78-year-old man presented with RPGN after a 7-year course of chronic proteinuria and
hematuria with stable renal function. A blood examination showed a high titer of myeloperoxidase (MPO)-ANCA.
A renal biopsy showed crescentic glomerulonephritis with abundant subepithelial, intramenbranous and
subendothelial deposits by electron microscopy, leading to the diagnosis of ANCA-associated CGN superimposed
on type 3 membranoproliferative glomerulonephritis (MPGN).
Conclusions: This case is unique in that type 3 MPGN and MPO-ANCA-associated CGN coexisted, and no similar
case has been reported to date. Because ANCA-associated CGN has a predilection for elderly individuals and
primary type 3 MPGN is rarely seen in this age group, coincidental existence appears less likely. This case may
confer valuable information regarding the link between immune complex and ANCA-associated CGN.
Keywords: Myeloperoxidase-antineutrophil cytoplasmic antibody, Membranoproliferative glomerulonephritis,
Immune complex, Rapidly progressive glomerulonephritisBackground
In elderly people, myeloperoxidase (MPO) and proteinase-
3 (PR3) antineutrophil cytoplasmic antibody (ANCA)-asso-
ciated crescentic glomerulonephritis (CGN) is a major
cause of rapidly progressive glomerulonephritis (RPGN).
ANCA-associated CGN is generally classified into pauci-
immune RPGN, in which there are few or no immune
complexes. We have experienced a rare case of ANCA-
associated CGN with extensive glomerular immune depos-
its supposed as type 3 membranoproliferative glomerulo-
nephritis (MPGN). Since idiopathic MPGN is rarely seen in
elderly subjects, coincidence of ANCA-associated CGN
and MPGN appears less likely. Here, we present a case
showing quite unique pathological findings and further* Correspondence: morizanr@da2.so-net.ne.jp
1Department of Internal Medicine, Keio University School of Medicine, 35
Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
Full list of author information is available at the end of the article
© 2012 Morizane et al.; licensee BioMed Centr
Commons Attribution License (http://creativec
reproduction in any medium, provided the ordiscuss the possible association between ANCA-associated
CGN and immune complex disease.Case presentation
A 78-year-old Japanese man was admitted to our
hospital because of rapidly declining renal function. The
patient had been treated for hypertension since the age
of 63 years at our hospital and was initially free of protein-
uria with normal renal function. Despite satisfactory control
of hypertension, he began to exhibit proteinuria with
microscopic hematuria at the age of 71 years. Proteinuria
gradually increased to 2 grams per day over the ensuing six
months. Laboratory and imaging studies for connective
tissue disease, malignancy, dysproteinemia, and hepatitis
viral infection were uninformative, but a test for antinuclear
antibodies was weakly positive and a high-resolution
computed tomography scan showed mild interstitial pneu-
monia. Although a renal biopsy was recommended at thisal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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received antihypertensive treatment under the close obse-
rvation. Proteinuria and microscopic hematuria persisted,
and his serum creatinine remained at the level of 1.2 to
1.4 mg/dL. Seven years after the onset of the proteinuria,
however, the patient’s serum creatinine level rose rapidly
from 1.4 mg/dL to 8.1 mg/dL over a period of 2 months,
and he was admitted to our hospital.
The patient was 167.5 cm tall and weighed 64.7 kg.
His blood pressure was 142/77 mmHg. His body tem-
perature was 35.8°C. The palpebral conjunctivae showed
pallor, and marked edema was present in the lower
extremities. No respiratory or neurologic abnormalities
were apparent.
Laboratory data are shown in Table 1. Serum creatinine
was markedly increased (i.e., 8.3 mg/dL). A urinalysis
showed massive proteinuria (i.e., 3+), and the sediment
contained 50 to 100 red blood cells/high power field as
well as granular and waxy casts. 24-hour urinary protein
excretion was 3.17 g. Serologic evaluation revealed the
presence of ANCA directed against myeloperoxidase
(MPO-ANCA) at 536 EU (normal, < 20 EU). The com-
puted tomography scan of the lung showed interstitial
pneumonia with reticular and ground glass opacity, pre-
dominantly in the peripheral lower lung accompanied
by a honeycomb appearance. Bilateral apical old inflam-
matory changes suggestive of healed tuberculosis were
also present.
Because of the rapidly declining renal function,
hemodialysis was started shortly after admission. A renal
biopsy was performed on the 7th hospital day. RenalTable 1 Laboratory data on admission
white blood cell count 8,900/mm3
hemoglobin 8.7 g/dL
plate let count 343,300/mm3
creatinine 8.3 mg/dL
urea nitrogen 65.1 mg/dL
total protein 5.2 g/dL
albumin 1.5 g/dL






aspartate amino transferase 25 IU/L
alanine amino transferase 13 IU/L
C3 71 mg/dL (normal, 60-116 mg/dL)
C4 42 mg/dL (normal, 15-44 mg/dL)
CH-50 49.4 U/mL (normal, 25.0-48.0 mg/dL)histological findings were as follows; six of the nine
glomeruli visible by light microscopy showed cellular
and/or fibrocellular crescents with focal endocapillary
hypercellularity (Figure 1). The capillary walls were dif-
fusely thickened. Diffuse epimembranous deposits that
were occasionally continuous with large mesangial and
subendothelial deposits were observed. Arteries and arte-
rioles were free of vasculitic changes. Immunofluorescent
studies revealed heavy, granular deposits of the capillary
walls that stained positive with antisera directed against
IgG, IgM, and C3 (Figure 2). Silver-impregnated sam-
ples observed using electron microscopy showed diffuse
glomerular basement membrane (GBM) thickening and re-
ticulation with large intra- and trans-membranous deposits.
The deposits were not concentrated in the lamina densa,
as was observed in dense-deposit disease (Figure 3).
The patient was treated with high-dose prednisolone
for 6 weeks following 3 days of intravenous pulse methyl-
prednisolone treatment. Cyclophosphamide was not ad-
ministered when his age and the risk of infection were
deliberately taken into consideration. Although the MPO-
ANCA titer decreased with steroid therapy, the patient’s
renal function failed to improve and prednisolone was
tapered. The patient was subsequently discharged from
the hospital and continued to receive maintenance
hemodialysis therapy on an outpatient basis.
Discussion
Our patient presented with a clinical picture of RPGN,
with a high serum titer of MPO-ANCA preceded by










hepatitis B antigen negative
hepatitis c antigen negative
KL-6 337 U/ml (normal, <500 U/mL
surfactant protein D 77 ng/mL (normal, 110 ng/mL)
surfactant protein A 56.5 ng/mL (normal, <43.8 U/mL
QuantiFERONW nagative
Figure 1 Light microscopy findings. a) Several crescents with focal endocapillary hypercellularity are visible in the glomeruli (Periodic acid-Schiff,
×200 original magnification). b) Glomeruli are showing endocapillary and extracapillary hypercellularity. The capillary walls are diffusely thickened.
c) Membranous deposits continuous with large mesangial and subendothelial deposits. The glomerular basement membrane shows numerous spikes
and reticulation (Methenamine sliver, ×1,000 original magnification).
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biopsy showed diffuse glomerular crescent formation
as well as abundant deposits and diffusely thickened
capillary walls by light microscopy. Because the co-existenceFigure 2 Immunofluorescence microscopy findings. Immunofluorescen
stained positive with antisera directed against IgG, IgM, and C3.of membranous nephropathy and ANCA-associated CGN
was shown in previous reports [1-5], we inferred a
priori that MPO-ANCA-associated CGN was superim-
posed on membranous nephropathy. Electron microscopict studies showed heavy, granular, epimembranous deposits that
Figure 3 Silver-impregnated specimens observed using electron microscopy. a) Low magnification (×300). The portion indicated by an
asterisk and an arrowhead are enlarged to b) and c) respectively. b) Numerous large intra- and trans-membranous electron-dense deposits
are visible (original magnification, ×1,000). c) Glomerular basement membrane shows a disrupted, reticulated and woven appearance
(original magnification, ×1,500).
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but also numerous intramembranous and subendothelial
deposits, which are rarely observed in membranous ne-
phropathy. These findings rather favor a diagnosis of
MPO-ANCA-associated CGN superimposed on type 3
MPGN, although mesangial proliferation was only mo-
dest. Type 3 MPGN, however, is rarely seen in elderly
people, and no reports have previously been made sho-
wing ANCA-associated CGN superimposed on type 3
MPGN.
It has been widely accepted that the paucity of immu-
noglobulin deposits distinguishes ANCA-associated CGN
from immune complex glomerulonephritis and anti-GBM
glomerulonephritis, leading to the belief that immune
complexes do not play a role in ANCA-associated CGN.
Nevertheless, several studies suggest that glomerularTable 2 Cases of secondary MPGN with positive ANCA
Diagnosis Type of ANCA Clinica
Rheumatoid arthritis p-ANCA 1:1000 nephrotic
shunt nephritis c-ANCA 1:1000 ELISA: 39 IU/ml proteinuria
carbamazepine induced
autoimmune
p-ANCA 1:1280 RPGNimmune complex deposition and ANCA-positivity are not
necessarily mutually exclusive. Falk et al. [6] demonstrated
that a considerable number of patients with immune com-
plex glomerulonephritis were positive for ANCA. Fur-
thermore, ANCA is reported to be detected in various
immune complex-mediated nephropathy, including IgA
nephropathy [7,8], post-infectious glomerulonephritis [9],
membranous nephropathy [5], lupus nephritis [10-12],
glomerulonephritis of hypocomplementemic urticarial
vasculitis syndrome [13], glomerulonephritis of hepatitis
C virus infection [14,15] and glomerulonephritis of su-
bacute bacterial endocarditis [16]. These observations sug-
gest a possible link between immune complex and ANCA
in a subset of glomerulonephritis.
Alternatively, Neumann et al. [17] evaluated 45 pa-
tients with systemic small vessel vasculitis and CGN orl course Renal pathology Reference
syndrome type 1 MPGN with crescent
IgG/M/C1q/C3 in subendothelium
[19]
(2.1 g/day) type 1 MPGN IgM/A/C3 in subepithelial [20]
type 1 MPGN with crescent
IgG/M/C1q/C3 in subendothelium
[21]
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deposition in 8 of 45 cases (18%), using the immune-
peroxidase method. Haas et al. [9] also demonstrated the
presence of electron-dense deposits in 68 cases (54%)
among 126 patients of CGN associated with ANCA and/
or necrotizing angiitis. Finally, in a study in which renal
biopsy was performed in 74 patients with primary
ANCA-associated systemic vasculitis, 23 cases (31%)
possess immune complex deposition, as assessed by
immunofluorescence and/or electron microscopy [18]. In
concert, the presence of glomerular immune complex
deposition does not preclude the presence of ANCA or
ANCA-associated CGN.
Our case has manifested clinical and pathological fea-
tures of MPO-ANCA-associated CGN with numerous
immune deposits, which is compatible with the diagnosis
of MPO-ANCA-associated CGN superimposed on idio-
pathic type 3 MPGN. It is well known that ANCA-
associated CGN has a predilection for elderly individuals
whereas primary type 3 MPGN is rarely seen in this age
group. Coincidental occurrence of the two conditions
therefore appears less likely. Alternatively, several studies
reveal positive ANCA in secondary MPGN (Table 2).
Constantin et al. [19] reported a patient of rheumatoid
arthritis with positive p-ANCA and type 1 MPGN. Fur-
thermore, Bonarek et al. [20] experienced a case of infected
cysto-atrial shunt with c-ANCA-positive type 1 MPGN.
Similarly, Lhotta et al. [21] reported a patient with
carbamazepine-induced cryoglobulinemia and p-ANCA-
positive MPGN. In our present case, however, we were un-
able to disclose any distinct disease condition that could
cause these two types of renal pathological changes. In this
regard, our patient manifests interstitial pneumonia and
positive antinuclear antibody, which prompts us to surmise
that this case has deranged autoimmune system that could
cause MPGN and ANCA-associated CGN. Of interest, a
couple of previous animal experiments showed a role of
immune complexes in the pathogenesis of ANCA-
associated CGN [22,23]. It requires further basic and
clinical studies to elucidate whether immune complex-
mediated diseases induce ANCA-associated CGN.
Conclusions
Herein, the authors present a case with unique patholo-
gical changes showing a possible link between ANCA-
associated nephropathy and immune complex. The
implication that immune complex-mediated glomerular
injury plays a pathogenetic role in a subset of ANCA-
associated crescentic glomerulonephritis warrants further
investigations.
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